Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients’ Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine
Figure 1
Kaplan-Meier survival analysis in advanced pancreatic cancer patients undergoing PPV with or without JTT. Curves for overall survival were estimated in the PPV plus JTT group and the PPV alone group by the Kaplan-Meier method, and a difference between survival curves was statistically analyzed using the log-rank test.
